Solasia Pharma KK
TSE:4597

Watchlist Manager
Solasia Pharma KK Logo
Solasia Pharma KK
TSE:4597
Watchlist
Price: 32 JPY 6.67% Market Closed
Market Cap: 7B JPY

Wall Street
Price Targets

Price Targets Summary
Solasia Pharma KK

Wall Street analysts forecast Solasia Pharma KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Solasia Pharma KK is 47.94 JPY with a low forecast of 47.47 JPY and a high forecast of 49.35 JPY.

Lowest
Price Target
47.47 JPY
48% Upside
Average
Price Target
47.94 JPY
50% Upside
Highest
Price Target
49.35 JPY
54% Upside
Solasia Pharma KK Competitors:
Price Targets
206650
EuBiologics Co Ltd
25% Upside
688331
RemeGen Co Ltd
27% Downside
BPMC
Blueprint Medicines Corp
0% Downside
LXRX
Lexicon Pharmaceuticals Inc
265% Upside
4593
Healios KK
22% Downside
87S
Roivant Sciences Ltd
63% Upside
AZT
Arcticzymes Technologies ASA
10% Upside
IVA
Inventiva SA
219% Upside

Revenue
Forecast

Revenue Estimate
Solasia Pharma KK

For the last 9 years the compound annual growth rate for Solasia Pharma KK's revenue is 4%. The projected CAGR for the next 2 years is 193%.

4%
Past Growth
193%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Solasia Pharma KK

Operating Income forecast
is not available for
Solasia Pharma KK

Net Income
Forecast

Net Income Estimate
Solasia Pharma KK

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Solasia Pharma KK's stock price target?
Price Target
47.94 JPY

According to Wall Street analysts, the average 1-year price target for Solasia Pharma KK is 47.94 JPY with a low forecast of 47.47 JPY and a high forecast of 49.35 JPY.

What is Solasia Pharma KK's Revenue forecast?
Projected CAGR
193%

For the last 9 years the compound annual growth rate for Solasia Pharma KK's revenue is 4%. The projected CAGR for the next 2 years is 193%.

Back to Top